BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Dominari A, Hathaway III D, Pandav K, Matos W, Biswas S, Reddy G, Thevuthasan S, Khan MA, Mathew A, Makkar SS, Zaidi M, Maher M, Beas R, Castaneda V, Paul T, Halpern J, Baralt D. Thymosin alpha 1: A comprehensive review of the literature. World J Virol 2020; 9(5): 67-78 [PMID: 33362999 DOI: 10.5501/wjv.v9.i5.67]
URL: https://www.wjgnet.com/2220-3249/full/v9/i5/67.htm
Number Citing Articles
1
Anastasios I. Birmpilis, Panagiotis Vitsos, Ioannis V. Kostopoulos, Lillian Williams, Kyriaki Ioannou, Pinelopi Samara, Chrysoula-Evangelia Karachaliou, Ioannis F. Voutsas, Elena Alyfanti, Nikolaos Angelis, Nikolaos G. Gavalas, Themis Gkraikou, Niki Kappa, Eleftheria Klagkou, Persefoni Klimentzou, Spiridoula Nikou, Nikos E. Papaioannou, Margarita Skopeliti, David Toukli, Meletios-Athanasios Dimopoulos, Aristotelis Bamias, Evangelia Livaniou, Hubert Kalbacher, Ourania E. Tsitsilonis, Wolfgang Voelter. Prothymosin α and its C-Terminal Immunoreactive Decapeptide Show No Evidence of Acute Toxicity: A Preliminary In Silico, In Vitro and In Vivo InvestigationCurrent Medicinal Chemistry 2022; 29(42): 6463 doi: 10.2174/0929867328666211117093401
2
Fadi Shehadeh, Gregorio Benitez, Evangelia K Mylona, Quynh-Lam Tran, Maria Tsikala-Vafea, Eleftheria Atalla, Matthew Kaczynski, Eleftherios Mylonakis. A Pilot Trial of Thymalfasin (Thymosin-α-1) to Treat Hospitalized Patients With Hypoxemia and Lymphocytopenia Due to Coronavirus Disease 2019 InfectionThe Journal of Infectious Diseases 2023; 227(2): 226 doi: 10.1093/infdis/jiac362
3
Michael Quagliata, Anna Maria Papini, Paolo Rovero. Therapeutic applications of thymosin peptides: a patent landscape 2018-presentExpert Opinion on Therapeutic Patents 2023; 33(12): 865 doi: 10.1080/13543776.2023.2298833
4
Association between pretreatment lymphocyte count and efficacy of immune-enhancing therapy in acute necrotising pancreatitis: a post-hoc analysis of the multicentre, randomised, placebo-controlled TRACE trialeClinicalMedicine 2023; 58: 101915 doi: 10.1016/j.eclinm.2023.101915
5
Yafeng Liu, Jibin Lu. Mechanism and clinical application of thymosin in the treatment of lung cancerFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1237978
6
Muhammad Shahbaz Aslam, Syed Zohaib Javaid Zaidi, Rabail Hassan Toor, Iram Gull, Muhammad Mudassir Iqbal, Zaigham Abbas, Imran Tipu, Aftab Ahmed, Muhammad Amin Athar, Christian Harito, Sammer-ul Hassan. Interferon α2–Thymosin α1 Fusion Protein (IFNα2–Tα1): A Genetically Engineered Fusion Protein with Enhanced Anticancer and Antiviral EffectMaterials 2021; 14(12): 3318 doi: 10.3390/ma14123318
7
Yatin Mehta, Subhal B Dixit, Kapil Zirpe, Randhir Sud, Palepu B Gopal, Parvaiz A Koul, Vijay K Mishra, Abdul S Ansari, Vijay S Chamle. Therapeutic Approaches in Modulating the Inflammatory and Immunological Response in Patients With Sepsis, Acute Respiratory Distress Syndrome, and Pancreatitis: An Expert Opinion ReviewCureus 2021;  doi: 10.7759/cureus.18393
8
Adriana Marques, Carla Torre, Rui Pinto, Bruno Sepodes, João Rocha. Treatment Advances in Sepsis and Septic Shock: Modulating Pro- and Anti-Inflammatory MechanismsJournal of Clinical Medicine 2023; 12(8): 2892 doi: 10.3390/jcm12082892
9
Shuai Wang, Wei Wei, Hui Yong, Zhao Zhang, Xiping Zhang, Xuejun Zhang, Shue Wang. Synergistic anti-cancer and attenuation effects of thymosin on chemotherapeutic drug vinorelbine in tumor-bearing zebrafishBiomedicine & Pharmacotherapy 2023; 162: 114633 doi: 10.1016/j.biopha.2023.114633
10
Christian Bode, Sebastian Weis, Andrea Sauer, Pedro Wendel-Garcia, Sascha David. Targeting the host response in sepsis: current approaches and future evidenceCritical Care 2023; 27(1) doi: 10.1186/s13054-023-04762-6
11
Arto Yuwono Soeroto, Hendarsyah Suryadinata, Theo Audi Yanto, Timotius Ivan Hariyanto. The efficacy of thymosin alpha-1 therapy in moderate to critical COVID-19 patients: a systematic review, meta-analysis, and meta-regressionInflammopharmacology 2023; 31(6): 3317 doi: 10.1007/s10787-023-01354-2
12
Yan Wu, Lingling He, Yongping Guo, Niansong Wang. Risk Factors and Drug Efficacy for Severe Illness in Hemodialysis Patients Infected with the Omicron Variant of COVID-19Kidney and Blood Pressure Research 2023; 48(1): 642 doi: 10.1159/000534192
13
Wilson Savino, Ailin Lepletier. Thymus-derived hormonal and cellular control of cancerFrontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1168186
14
Zirui Wang, Cong Wang, Xiaohua Fei, Haixing Wu, Peiqin Niu, Changxing Shen. Thymalfasin therapy accelerates COVID-19 pneumonia rehabilitation through anti-inflammatory mechanismsPneumonia 2023; 15(1) doi: 10.1186/s41479-023-00116-6
15
Tao Liu, Shengdong Liu, Tao Li, Jingjing Zhang. Thymosin a1 use is not associated with reduced COVID-19 mortalityThe American Journal of Emergency Medicine 2022; 53: 252 doi: 10.1016/j.ajem.2021.04.043
16
Ángel Bulnes-Ramos, María Mar Pozo-Balado, Israel Olivas-Martínez, Vanesa Garrido-Rodríguez, Gabriel Bernal-Blanco, Alejandro Suárez-Benjumea, Ana Isabel Álvarez-Ríos, Carmen Lozano, Carmen González-Corvillo, Marta Suñer-Poblet, Francisco Manuel González-Roncero, Berta Sánchez, Isabel Maldonado-Calzado, José Manuel Lara-Ruiz, María Francisca Gonzalez-Escribano, Yolanda María Pacheco. Factors associated with the humoral response after three doses of COVID-19 vaccination in kidney transplant recipientsFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1099079
17
Lisa K. Torres, Peter Pickkers, Tom van der Poll. Sepsis-Induced ImmunosuppressionAnnual Review of Physiology 2022; 84(1): 157 doi: 10.1146/annurev-physiol-061121-040214
18
Daniela Ricci, Marilena Paola Etna, Martina Severa, Stefano Fiore, Fabiana Rizzo, Marco Iannetta, Massimo Andreoni, Stefano Balducci, Paola Stefanelli, Anna Teresa Palamara, Eliana Marina Coccia. Novel evidence of Thymosin α1 immunomodulatory properties in SARS-CoV-2 infection: Effect on innate inflammatory response in a peripheral blood mononuclear cell-based in vitro modelInternational Immunopharmacology 2023; 117: 109996 doi: 10.1016/j.intimp.2023.109996
19
Cesidio Giuliani, Sara Verrocchio, Fabio Verginelli, Ines Bucci, Antonino Grassadonia, Giorgio Napolitano. Hormonal Regulation of the MHC Class I Gene in Thyroid Cells: Role of the Promoter “Tissue-Specific” RegionFrontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.749609
20
Valéria Bumiller-Bini Hoch, Ana Flávia Kohler, Danillo G. Augusto, Sara Cristina Lobo-Alves, Danielle Malheiros, Gabriel Adelman Cipolla, Angelica Beate Winter Boldt, Karin Braun-Prado, Michael Wittig, Andre Franke, Claudia Pföhler, Margitta Worm, Nina van Beek, Matthias Goebeler, Miklós Sárdy, Saleh Ibrahim, Hauke Busch, Enno Schmidt, Jennifer Elisabeth Hundt, Patrícia Savio de Araujo-Souza, Maria Luiza Petzl-Erler. Genetic Associations and Differential mRNA Expression Levels of Host Genes Suggest a Viral Trigger for Endemic Pemphigus FoliaceusViruses 2022; 14(5): 879 doi: 10.3390/v14050879
21
María del Mar Pozo-Balado, Ángel Bulnes-Ramos, Israel Olivas-Martínez, Vanesa Garrido-Rodríguez, Carmen Lozano, Ana I. Álvarez-Ríos, Berta Sánchez-Sánchez, Encarnación Sánchez-Bejarano, Isabel Maldonado-Calzado, José Manuel Martín-Lara, Juan Antonio Santamaría, Rafael Bernal, María Francisca González-Escribano, Manuel Leal, Yolanda M. Pacheco. Higher plasma levels of thymosin-α1 are associated with a lower waning of humoral response after COVID-19 vaccination: an eight months follow-up study in a nursing homeImmunity & Ageing 2023; 20(1) doi: 10.1186/s12979-023-00334-y
22
ChenLu Huang, Ling Fei, Wei Xu, WeiXia Li, XuDong Xie, Qiang Li, Liang Chen. Efficacy Evaluation of Thymosin Alpha 1 in Non-severe Patients With COVID-19: A Retrospective Cohort Study Based on Propensity Score MatchingFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.664776